Home/Filings/4/0001179110-20-006356
4//SEC Filing

OH ANDREW M. 4

Accession 0001179110-20-006356

CIK 0001709401other

Filed

May 18, 8:00 PM ET

Accepted

May 19, 8:02 PM ET

Size

6.6 KB

Accession

0001179110-20-006356

Insider Transaction Report

Form 4
Period: 2020-05-15
OH ANDREW M.
Chief Financial Officer
Transactions
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2020-05-155,000755,500 total
    Exercise: $4.74Exp: 2028-02-14Common Stock (5,000 underlying)
  • Exercise/Conversion

    Common Stock

    2020-05-15$4.74/sh+5,000$23,7005,000 total
Footnotes (1)
  • [F1]25% of this option shall vest on December 13, 2018, then in 12 equal quarterly installments thereafter.

Issuer

Rubius Therapeutics, Inc.

CIK 0001709401

Entity typeother

Related Parties

1
  • filerCIK 0001746614

Filing Metadata

Form type
4
Filed
May 18, 8:00 PM ET
Accepted
May 19, 8:02 PM ET
Size
6.6 KB